Btk And Bcl-2 Activity At Baseline Predicts Mrd Status For Chronic Lymphocytic Leukemia Patients Treated With Ibrutinib + Venetoclax In The Hovon 141/Vision Trial
Ibrutinib;Venetoclax
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Btk And Bcl-2 Activity At Baseline Predicts Mrd Status For Chronic Lymphocytic Leukemia Patients Treated With Ibrutinib + Venetoclax In The Hovon 141/Vision Trial ### Output: Ibrutinib;Venetoclax